Wednesday , February 26 2020
Home / Mercatus Center / Regulators Wonder if Cancer Patients ‘Need’ New Treatments

Regulators Wonder if Cancer Patients ‘Need’ New Treatments

Summary:
Matthew D. Mitchell and Anna Parsons write on regulatory hurdles faced in introducing a new cancer drug, despite the drug already having been approved by the FDA. Read it at the Wall Street Journal.

Topics:
Matthew D. Mitchell, Anna Parsons considers the following as important:

This could be interesting, too:

Don Boudreaux writes Quotation of the Day…

Tom Woods writes Ep. 1598 Common Logical Fallacies That Need to Be Smashed

Wolf Richter writes The Most Splendid Housing Bubbles in America, Feb. Update

Tyler Durden writes South Korea Confirms 169 New Cases As Total Surpasses 1,000; China Reports Drop In Deaths

Matthew D. Mitchell and Anna Parsons write on regulatory hurdles faced in introducing a new cancer drug, despite the drug already having been approved by the FDA.

Read it at the Wall Street Journal.

Leave a Reply

Your email address will not be published. Required fields are marked *